driving cellular function
inspiring scientific discovery
Our mitochondrial MitoRCI research platform allows us the ability to better predict the mitochondrial function of drug candidates.
Mitochondrial function profiling (Seahorse bioscience XF platform) and high content imaging can accurately determine the mechanism of action (MOA) and/or mitochondrial toxicity profile of lead compounds.
WHO WE ARE
Founded in 2011, BioEnergetics is a pre-clinical CRO that is managed by mitochondrial experts who can help evaluate, design and execute complex and challenging mitochondria studies.
“We design studies to address our client’s scientific and business goals"
Tom N. Grammatopoulos PhD, Founder